Phase II study of paclitaxel and carboplatin for malignant melanoma.
about
Treatment of metastatic melanoma: an overviewPreliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma.Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study.A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1)Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanomaTargeted therapy for melanoma: a primer.Pathogenesis, diagnosis and management of primary melanoma of the colon.The history and future of chemotherapy for melanoma.Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors.Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.Sorafenib: delivering a targeted drug to the right targets.Emerging therapies for melanoma.Current systemic therapy for metastatic melanoma.Novel therapeutics for the treatment of metastatic melanoma.Sequential Combination Chemotherapy of Dacarbazine (DTIC) with Carboplatin and Paclitaxel for Patients with Metastatic Mucosal Melanoma of Nasal Cavity and Paranasal Sinuses.Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanomaSorafenib in melanoma.What is the role of chemotherapy in the treatment of melanoma?Nab-paclitaxel in patients with metastatic melanoma.Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agentA phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma.NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.Combination chemotherapy of carboplatin and paclitaxel for metastatic melanoma.
P2860
Q24642384-4B222AB9-769D-4645-92BA-708029E994C9Q33379895-820595D9-DD6E-4E6B-98F9-621CE3549E9AQ33382481-87EA5149-C915-4C76-BC4F-C50C5C23EF11Q33390287-6BA224BF-D0A2-4925-B344-EABF7251D383Q33394828-8C456D17-0128-40D3-A958-BBD237584CDFQ33667485-425B1E17-0541-4750-93A1-30EE4097CCC1Q33831923-0CA7A429-2043-4A98-8211-489AA55E9484Q34540273-78A5D70F-3811-4B00-94C7-4FAB4842AFB7Q34581251-37B70CBE-EF43-4FB5-A1D4-32D25F4A8525Q34608084-44E4C2AB-07DB-4FC1-BAEE-F29537E16030Q36643696-6E2FFE09-1DF3-4857-8FE2-E88710EB8110Q36691820-6756AEB6-A6A7-4928-84B8-B3572A7E2B5BQ36817095-BF361C9A-F6A8-4A14-B7ED-36564E054920Q37134426-B13FF581-44C8-44BF-BBEE-9E3447C8BDADQ37483961-81725417-B2AF-41DE-80F6-81ACEE5363C5Q37486788-BEB75221-DB77-4E99-A1E7-3FC255A9186CQ37577095-F3791CB8-1A2C-452C-8CD7-B976335E0608Q37702351-B6E52EC3-5DD5-4229-9085-A1C1DD424829Q37990977-D8DB6ADA-E718-46D8-871F-587705C62309Q38193716-566BE0C2-E18D-498E-B274-FEFA4CD9BD76Q38625186-11CB27C6-E937-4F7C-9491-50C53DD26DF7Q39262145-9A3AF4C7-3ACA-4F8B-AB41-9BF6BAAAA33CQ40294106-78183FFF-1E8B-4D53-AD5A-6CF69DA492ECQ47240250-7D139DED-72BE-4330-B2C9-CA3DECB80A56Q54453189-8676A6C1-1634-4239-AE1C-DD94B0220F4C
P2860
Phase II study of paclitaxel and carboplatin for malignant melanoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Phase II study of paclitaxel and carboplatin for malignant melanoma.
@en
Phase II study of paclitaxel and carboplatin for malignant melanoma.
@nl
type
label
Phase II study of paclitaxel and carboplatin for malignant melanoma.
@en
Phase II study of paclitaxel and carboplatin for malignant melanoma.
@nl
prefLabel
Phase II study of paclitaxel and carboplatin for malignant melanoma.
@en
Phase II study of paclitaxel and carboplatin for malignant melanoma.
@nl
P2093
P1476
Phase II study of paclitaxel and carboplatin for malignant melanoma.
@en
P2093
Dianne M Finkelstein
F Stephen Hodi
Frank G Haluska
Jeffrey Clark
Robert J Soiffer
P304
P356
10.1097/00000421-200206000-00016
P577
2002-06-01T00:00:00Z